Lovastatin Preserves Renal Function in Experimental Diabetes
- 1 April 1999
- journal article
- research article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 317 (4) , 215-221
- https://doi.org/10.1097/00000441-199904000-00001
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Renal hemodynamic effects of lovastatin in a renal ablation modelUrology, 1996
- Cholesterol-lowering therapy may retard the progression of diabetic nephropathyDiabetologia, 1995
- The combination of lovastatin and enalapril in a model of progressive renal diseasePediatric Nephrology, 1994
- Lovastatin Retards the Progression of Established Glomerular Disease in Obese Zucker RatsAmerican Journal of Kidney Diseases, 1993
- Lovastatin inhibits proliferation of rat mesangial cells.Journal of Clinical Investigation, 1993
- Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats.Hypertension, 1992
- Lovastatin Ameliorates the Development of Glomerulosclerosis and Uremia in Experimental Nephrotic SyndromeAmerican Journal of Kidney Diseases, 1990
- Treatment of hyperlipidemia reduces glomerular injury in obese Zucker ratsKidney International, 1988
- Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure.Circulation Research, 1988
- Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl ratsKidney International, 1984